artrix, Author at 维梧资本|专注医疗健康领域的投资公司

关于 artrix

该作者尚未填入任何详情。
目前artrix已创建了71篇文章.

Portfolio Company, Kadmon received FDA approval for REZUROCK
Gallery
Portfolio Company, Kadmon received FDA approval for REZUROCK

全部新闻, 美国投资项目

Portfolio Company, Kadmon received FDA approval for REZUROCK

Portfolio Company, Kadmon received FDA approval for REZUROCKartrix2021-07-18T21:03:52-07:00

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!
Gallery
Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!

全部新闻, 美国投资项目

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!

Vivo is Excited to Announce the IPO of Portfolio Company, Sera Prognostics!artrix2021-07-18T21:02:34-07:00

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use
Gallery
World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use

全部新闻, 美国投资项目

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Use

World Health Organization (“WHO”) Authorizes a Vivo Portfolio Company Sinovac Biotech, for Emergency Useartrix2021-06-01T20:29:23-07:00

Vivo Capital invests $50mm in Scientia Vascular
Gallery
Vivo Capital invests $50mm in Scientia Vascular

全部新闻, 美国投资项目

Vivo Capital invests $50mm in Scientia Vascular

Vivo Capital invests $50mm in Scientia Vascularartrix2021-06-01T20:28:12-07:00

Vivo leads Esco’s $200 million Series A
Gallery
Vivo leads Esco’s $200 million Series A

全部新闻, 美国投资项目

Vivo leads Esco’s $200 million Series A

Vivo leads Esco’s $200 million Series Aartrix2021-05-27T13:48:46-07:00

Vivo invests in a Rgenta
Gallery
Vivo invests in a Rgenta

全部新闻, 美国投资项目

Vivo invests in a Rgenta

Vivo invests in a Rgentaartrix2021-05-27T13:49:49-07:00

Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticals
Gallery
Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticals

全部新闻, 美国投资项目

Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticals

Vivo Capital’s venture portfolio company AADI announces a merger agreement with Aerpio Pharmaceuticals with a concurrent $155M in PIPE financing by Aerpio Pharmaceuticalsartrix2021-05-22T13:35:48-07:00

Vivo Leads the $25M Aerobiotix, Inc. Growth Equity Deal
Gallery
Vivo Leads the $25M Aerobiotix, Inc. Growth Equity Deal

全部新闻, 美国投资项目

Vivo Leads the $25M Aerobiotix, Inc. Growth Equity Deal

Vivo Leads the $25M Aerobiotix, Inc. Growth Equity Dealartrix2021-05-07T12:25:48-07:00

Vivo Invests in Sera Prognostics’ $100 Million Series E Financing
Gallery
Vivo Invests in Sera Prognostics’ $100 Million Series E Financing

全部新闻, 美国投资项目

Vivo Invests in Sera Prognostics’ $100 Million Series E Financing

Vivo Invests in Sera Prognostics’ $100 Million Series E Financingartrix2021-05-05T07:29:38-07:00

Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work
Gallery
Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work

全部新闻, 美国投资项目

Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer work

Bolt Biotherapeutics strikes a major upsized $230M IPO [...]

Bolt Biotherapeutics strikes a major upsized $230M IPO for next-gen cancer workartrix2021-02-08T23:13:54-08:00